يعرض 1 - 10 نتائج من 62 نتيجة بحث عن '"Ramachandran Venkitaraman"', وقت الاستعلام: 1.72s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Howell, S J, Casbard, A, Carucci, M, Ingarfield, K, Butler, R, Morgan, S, Meissner, M, Bale, C, Bezecny, P, Moon, S, Twelves, C, Venkitaraman, R, Waters, S, de Bruin, E C, Schiavon, G, Foxley, A & Jones, R H 2022, ' Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION) : overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial ', The Lancet. Oncology, vol. 23, no. 7, pp. 851-864 . https://doi.org/10.1016/S1470-2045(22)00284-4

  4. 4

    المصدر: International Journal of Radiation Oncology, Biology, Physics
    Huddart, R, Hafeez, S, Lewis, R, McNair, H, Syndikus, I, Henry, A, Staffurth, J, Dewan, M, Vassallo-Bonner, C, Moinuddin, S A, Birtle, A, Horan, G, Rimmer, Y, Venkitaraman, R, Khoo, V, Mitra, A, Hughes, S, Gibbs, S, Kapur, G, Baker, A, Hansen, V N, Patel, E, Hall, E & HYBRID Investigators 2021, ' Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer ', International Journal of Radiation Oncology, Biology, Physics, vol. 110, no. 2, pp. 412-424 . https://doi.org/10.1016/j.ijrobp.2020.11.068

    وصف الملف: application/pdf

  5. 5
  6. 6

    المساهمون: Institut Català de la Salut, [de Las Heras B] Covance Inc., Princeton, NJ, USA. Madrid Medical Doctors Association, Madrid, Spain. [Saini KS] Covance Inc., Princeton, NJ, USA. East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK. [Boyle F] Mater Hospital, Sydney, Australia. [Ades F] Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. [de Azambuja E] Institut Jules Bordet, Brussels, Belgium. Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. [Bozovic-Spasojevic I] Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. [Capelan M] Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Oncology and Therapy
    Scientia
    Oncology and Therapy, Vol 8, Iss 2, Pp 171-182 (2020)

    وصف الملف: application/pdf

  7. 7
  8. 8
  9. 9

    المصدر: Jones, R, Casbard, A, Carucci, M, Cox, C, Butler, R, Alchami, F, Madden, T-A, Bale, C, Bezecny, P, Joffe, J, Moon, S, Twelves, C, Venkitaraman, R, Waters, S, Foxley, A & Howell, S 2020, ' Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION) : a multicentre, randomised, controlled, phase 2 trial ', The Lancet Oncology, vol. 21, no. 3, pp. 345-357 . https://doi.org/10.1016/S1470-2045(19)30817-4

  10. 10